AOD 9604 (also known as a hexapeptide auxin analogue) is a modified fragment of human growth hormone (HGH), specifically fragment 176-191. This hormone fragment is thought to have fat-burning (lipolysis) properties, but lacks the growth-promoting (and potential glycemic) effects of the intact HGH molecule.
Theory: The Principle of Weight Loss
Its expected mechanism of action involves two aspects:
1. Stimulating lipolysis: It signals fat cells (adipose tissue) to break down stored triglycerides into free fatty acids, which can then be used for energy.
2. Inhibiting fat storage (lipogenesis): It also prevents the body from producing and storing new fat.
Based on this mechanism, the expected result is weight loss, especially fat reduction, rather than weight gain.
So, why do some people believe it leads to weight gain?
While some people may associate AOD 9604 with weight gain for various reasons, this is usually a misconception or related to other factors:
1. Water Retention: Although AOD 9604 is designed to prevent this, some people may experience mild water retention, which can cause a temporary increase in the number on the scale. This is not fat gain.
2. Increased Appetite: Some users report a slight increase in hunger. If this leads to calorie intake exceeding calorie expenditure, actual weight gain (fat or muscle) may occur. This weight gain is not caused by the peptide itself, but by a calorie surplus.
3. Inappropriate Product or Dosage: The peptide drug market is poorly regulated. Users may be taking impure products, incorrectly labeled medications, or taking incorrect dosages, resulting in a failure to achieve the desired effect.
4. Combination with Other Therapies: If someone uses AOD 9604 with other supplements or medications (e.g., medications that cause insulin resistance or increased appetite), weight gain may still occur even with AOD.
5. Misuse: Users may confuse AOD 9604 with other growth hormone secretagogues (such as GHRP-6 or MK-677), which are known for significantly increasing appetite and can easily lead to weight gain if diet is not controlled.
Conclusion: Evidence vs. Reality
● Animal Studies: Early studies in obese mice showed promising fat-loss effects.
● Human Studies: A large Phase IIb human clinical trial failed to demonstrate that AOD 9604 was more effective than placebo in reducing weight over 12 weeks. This is the main reason it has never been approved by the FDA as a weight-loss drug.
● Anecdotal Evidence: User feedback in the bodybuilding and biohacking communities is mixed. Some are convinced of its effectiveness in "spot reduction" (e.g., belly fat), while others report no noticeable effect. AOD 9604 (also known as a hexapeptide growth hormone analog) is a modified fragment of human growth hormone (HGH), specifically fragment 176-191. This hormone fragment is believed to have fat-burning (lipolysis) properties, but lacks the growth-promoting (and potential blood sugar-regulating) effects of the complete HGH molecule.
Theory: The Principle of Weight Loss
Its expected mechanism of action involves two aspects:
1. Stimulating lipolysis: It signals fat cells (adipose tissue) to break down stored triglycerides into free fatty acids, which can then be used for energy.
2. Inhibiting fat storage (lipogenesis): It also prevents the body from producing and storing new fat.
Based on this mechanism, the expected result is weight loss, particularly fat loss, rather than weight gain.
So why would anyone think it causes weight gain?
While some people may associate AOD 9604 with weight gain for various reasons, this is usually a misconception or related to other factors:
1. Water retention: Although AOD 9604 is designed to avoid this, some people may experience mild water retention, which can cause a temporary increase in the number on the scale. This is not fat gain.
2. Increased Appetite: Some users reported a slight increase in hunger. If this leads to calorie intake exceeding calorie expenditure, actual weight gain (fat or muscle) may occur. This weight gain is not caused by the peptide itself, but by a calorie surplus.
3. Inappropriate Product or Dosage: The peptide drug market is poorly regulated. Users may consume impure products, incorrectly labeled medications, or incorrect dosages, resulting in a failure to achieve the desired effect.
4. Combination with Other Therapies: If someone uses AOD 9604 with other supplements or medications (e.g., those causing insulin resistance or increased appetite), weight gain may still occur even with AOD.
5. Misuse: Users may confuse AOD 9604 with other growth hormone secretagogues (such as GHRP-6 or MK-677), which are known for significantly increasing appetite and can easily lead to weight gain if diet is not controlled.
Conclusion: Evidence and Reality
● Animal Studies: Early studies in obese mice showed promising fat-loss effects.
● Human Studies: A large Phase IIb human clinical trial failed to demonstrate that AOD 9604 was more effective than placebo in reducing weight over 12 weeks. This is the main reason it has never received FDA approval as a weight-loss drug.
● Anecdotal Evidence: User feedback within the bodybuilding and biohacking communities is mixed. Some are convinced of its effectiveness in "spot reduction" (such as reducing belly fat), while others report no noticeable results.